Novartis Home

Novartis associates working in a new cell and gene facility in Stein, Switzerland

At Novartis, we are reimagining medicine

Environmental, Social and Governance (ESG) Index

Novartis aims to report comprehensively and transparently about ESG topics. We have created the Novartis ESG Index to signpost where our key disclosures can be found across our publications and channels. 

Read More

World Cancer Day 2020

Novartis is supporting World Cancer Day through a dedicated global workplace program called Ensemble – Caring for Colleagues.

Learn More

Novartis 2019 Financial Results 

Novartis announces the company’s fourth quarter and 2019 full year financial results.

Learn More 

Annual Review 2019

The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2019.

Learn More

Novartis at the World Economic Forum Annual Meeting Davos 2020

Novartis attended the 2020 World Economic Forum Annual Meeting in Davos, with the theme ‘Stakeholders for a Cohesive and Sustainable World’.

Learn More

Novartis and Microsoft AI collaboration

Novartis and Microsoft announced their collaboration to transform medicine with artificial intelligence.

Read More

Accelerating our digital transformation with Amazon Web Services (AWS)

We are collaborating with AWS to build an enterprise-wide data and analytics platform to help transform business operations, starting with the way medicines are manufactured and delivered.

Read More

Cell & Gene Therapy at Novartis

We are reimagining medicine to power breakthrough innovation in cell and gene therapy.

Learn More